Ligand Pharmaceuticals
LGND
#3601
Rank
HK$28.32 B
Marketcap
HK$1,439
Share price
-1.93%
Change (1 day)
49.74%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Net assets

Net assets on the balance sheet as of September 2025 : HK$7.39 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has HK$7.39 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ligand Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$6.44 B17.77%
2023-12-31$HK$5.47 B17.26%
2022-12-31$HK$4.66 B-27.09%
2021-12-31$HK$6.40 B16.41%
2020-12-31$HK$5.50 B-7.95%
2019-12-31$HK$5.97 B36.03%
2018-12-31$HK$4.39 B34.29%
2017-12-31$HK$3.27 B13.74%
2016-12-31$HK$2.87 B33.99%
2015-12-31$HK$2.14 B1033.66%
2014-12-31$HK$0.18 B-50.79%
2013-12-31$HK$0.38 B87.4%
2012-12-31$HK$0.20 B222.93%
2011-12-31$HK$63.57 M-268.47%
2010-12-31$-HK$37.74 Million-229.99%
2009-12-31$HK$29.02 M-136.24%
2008-12-31$-HK$80.1 Million-135.28%
2007-12-31$HK$0.22 B6.71%
2006-12-31$HK$0.21 B-124.85%
2005-12-31$-HK$0.86 Billion46.27%
2004-12-31$-HK$0.59 Billion101.07%
2003-12-31$-HK$0.3 Billion-150.43%
2002-12-31$HK$0.57 B-227.9%
2001-12-31$-HK$0.46 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
HK$74.88 B 912.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
HK$0.20 B-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$164.84 B 2,128.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$404.07 B 5,362.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$724.71 B 9,697.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$185.66 B 2,410.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$144.79 B 1,857.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
HK$56.15 B 659.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$617.13 B 8,243.45%๐Ÿ‡บ๐Ÿ‡ธ USA